Granite Point Capital Management’s NEVRO CORP. NVRO Stock Holding History

Granite Point Capital Management’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-27,200	Closed	-$1.88M	–	126
2017 Q4	$1.88M	Sell	27,200 -900	-3%	-$72K	0.18%	32
2017 Q3	$2.55M	Sell	28,100 -3,900	-12%	-$334K	0.54%	19
2017 Q2	$2.38M	Sell	32,000 -5,000	-14%	-$401K	0.59%	27
2017 Q1	$3.47M	Sell	37,000 -13,000	-26%	-$1.18M	1.04%	14
2016 Q4	$3.63M	Buy	50,000 +2,200	+5%	+$188K	2.9%	10
2016 Q3	$4.99M	Sell	47,800 -25,675	-35%	-$2.32M	1.95%	11
2016 Q2	$5.42M	Buy	+73,475	New	+$4.99M	2.33%	6
2015 Q4	$8.44M	Buy	125,000 +9,073	+8%	+$486K	1.26%	3
2015 Q3	$5.38M	Sell	115,927 -50,523	-30%	-$2.45M	3.69%	4
2015 Q2	$8.95M	Buy	166,450 +110,050	+195%	+$5.61M	2.6%	3
2015 Q1	$2.7M	Buy	+56,400	New	+$2.45M	0.99%	18

Other funds holding NVRO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Granite Point Capital Management's NVRO Position: Q1 2018 in Review

Granite Point Capital Management sold out of NEVRO CORP. (NVRO) in Q1 2018, closing a stake of 27,200 shares — an estimated $1.88M sold.

Granite Point Capital Management first reported a position in NVRO in Q1 2015 and held it in 11 quarters. The position peaked at $8.95M in Q2 2015. 197 funds tracked by Wall St. Rank hold NVRO as of Q1 2018.

Granite Point Capital Management reported no remaining NEVRO CORP. position as of Q1 2018 after selling out during the quarter.
Granite Point Capital Management sold 27,200 NEVRO CORP. shares in Q1 2018, an estimated $1.88M.
Granite Point Capital Management first reported a position in NEVRO CORP. in Q1 2015 and held it in 11 quarters.
Granite Point Capital Management's NEVRO CORP. position peaked at $8.95M in Q2 2015.
197 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2018.

Based on Granite Point Capital Management's 13F filing for Q1 2018, filed 15 May 2018.